CONMED CORP's ticker is and the CUSIP is 207410951. A total of 2 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,017,000 | -85.8% | 20,000 | -80.8% | 0.00% | -80.0% |
| Q2 2023 | $14,159,738 | +432.6% | 104,200 | +307.0% | 0.01% | +400.0% |
| Q1 2023 | $2,658,816 | -25.8% | 25,600 | -36.6% | 0.00% | -50.0% |
| Q4 2022 | $3,581,056 | +228.5% | 40,400 | +197.1% | 0.00% | – |
| Q3 2022 | $1,090,000 | +12.7% | 13,600 | +34.7% | 0.00% | – |
| Q2 2022 | $967,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 10,100 | $967,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |